Beyaz önlük hipertansiyonunda uç organ hasarı ile vücut kitle indeksi arasındaki ilişki

Amaç: Beyaz önlük hipertansiyonu (BÖH) poliklinik ölçümlerinde

Anahtar Kelimeler:

Hipertansiyon, Vücut Kitle İndeksi, Kan basıncı

The relation between body mass index and end organ damage in white coat hypertension

Objective: White coat hypertension (WCH) is characterized by

Keywords:

Hypertension, Body Mass Index, Blood Pressure,

PDF

___

1. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease.Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-74. doi: 10.1016/0140-6736(90)90878-9
2. O’Brien E, Coats A, Owens P, et al. Use and interpretation of ambulatory blood pressure monitoring: recommendations of the British hypertension society. BMJ 2000; 320(7242):1128- 34. doi: 10.1136/bmj.320.7242.1128
3. Erdogan D, Caliskan M, Gullu H, et al. Aortic elastic properties and left ventricular diastolic function in white-coat hypertensive individuals. Blood Press Monit 2006; 11: 191- 8. doi: 10.1097/01.mbp.000.020.9079.17246.7d
4. Ihm SH, Youn HJ, Park CS, et al. Target organ status in white-coat hypertensives: usefulness of serum procollagen type I propeptide in the respect of left ventricular diastolic dysfunction. Circ J 2009; 73: 100-5. doi: 10.1253/circj.CJ- 08-0464
5. Ben-Dov IZ, Kark JD, Mekler J, Shaked E, Bursztyn M. The white coat phenomenon is benign in referred treated patients: a 14-year ambulatory blood pressure mortality study. J Hypertens 2008; 26: 699-705. doi: 10.1097/ HJH.0b013e3282f4b3bf
6. Pioli MR, Ritter AM, de Faria AP, Modolo R. White coat syndrome and its variations: differences and clinical impact. Integr Blood Press Control 2018;11:73-9. doi:10.2147/IBPC. S152761
7. Seravalle G, Grassi G. Obesity and hypertension. Pharmacol Res 2017;122:1–7. doi: 10.1016/j.phrs.2017.05.013.
8. James PA, Oparil S, Carter BL, et al. 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014;311:507-20. doi: 10.1001/jama.2013.284427
9. Wagener HP, Clay GE, Gipner JF. Classification of retinal lesions in the presence of vascular hypertension: Report submitted to the American Ophthalmological Society by the committee on Classification of Hypertensive Disease of the Retina. Trans Am Ophthalmol Soc 1947; 45: 57-73.
10. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/ AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/ NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/ American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 2018; 71:e13. doi: 10.1161/ HYP.000.000.0000000066
11. Julius S, Mejia A, Jones K, et al. “White coat” versus “sustained” borderline hypertension in Tecumseh, Michigan. Hypertension 1990; 16:617-23.
12. Muscholl MW, Hense HW, Brüockel U, Düoring A, Riegger GAJ, Schunkert H. Changes in left ventricular structure and function in patients with white coat hypertension: crosssectional survey. Lancet 1998;317:565-70.
13. Verdecchia P, Schillaci G, Borgioni C, et al. White coat hypertension and white coat effect. Similarities and differences. Am J Hypertens 1995; 8:790-8. doi: 10.1016/0895-7061(95)00151-E
14. Owens PE, Lyons SP, Rodriguez SA, O’Brien ET. Is elevation of clinic blood pressure in patients with white coat hypertension who have normal ambulatory blood pressure associated with target organ changes? J Hum Hypertens 1998;12:743-8.
15. Martínez MA, Moreno A, Aguirre de Cárcer A, Cabrera R, Rocha R, Torre A. Frequency and determinants of microalbuminuria in mild hypertension: a primary-carebased study. J Hypertens 2001; 19: 319-26.
16. Di Mauro S, Spallina G, Scalia G, et al. Urinary albumin excretion in elderly patients with white coat hypertension. Arch Gerontol Geriatr 1999; 28: 23-9. doi: 10.1016/S0167- 4943(98)00121-6
17. Kristensen KS, Hoegholm A, Bang LE, Gustavsen PH, Poulsen CB. No impact of blood pressure variability on microalbuminuria and left ventricular geometry: analysis of daytime variation, diurnal variation and ‘white coat’ effect. Blood Press Monit 2001; 6:125-31.
18. Palatini P, Mormino P, Santonastaso M, et al. Target-organ damage in stage I hypertensive subjects with white coat and sustained hypertension: results from the HARVEST study. Hypertension 1998; 31: 57-63.
19. Schmieder RE, Messerli FH. Does obesity influence early target organ damage in hypertensive patients? Circulation 1993; 87:1482-88.
20. Wong TY, Klein R, Sharrett AR, et al. Retinal arteriolar diameter and risk for hypertension. Ann Intern Med 2004; 140:248-55. doi: 10.7326/0003-4819-140-4- 200402.170.00006
21. Pose-Reino A, González-Juanatey JR, Pastor C, et al. Clinical implications of white coat hypertension. Blood Press 1996; 5:264-73. doi: 10.3109/080.370.59609078058
22. Cerasola G, Cottone S, Nardi E, et al. White-coat hypertension and cardiovascular risk. J Cardiovasc Risk 1995; 2:545-9. doi: 10.1177/174.182.679500200609